SHP-1 expression in primary central nervous system B-cell lymphomas in immunocompetent patients reflects maturation stage of normal B cell counterparts

Pathology International

Volumn 54, Issue 9, 2004, Pages 659-666

  Sugita, Yasuo ^a   Tokunaga, Osamu ^a   Nakashima, Akihiko ^b   Shigemori, Minoru ^c  

^a SAGA UNIVERSITY   (Japan)

^b Saisekai Fukuoka General Hospital   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bcl 6; Central nervous system lymphomas; Germinal center; IgH polymerase chain reaction analysis; Immunocompetent hosts; SHP 1

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKINE; GROWTH FACTOR; MEMBRANE PROTEIN; PROTEIN BCL 6; PROTEIN TYROSINE PHOSPHATASE SHP 1; SYNDECAN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BRAIN LYMPHOMA; CELL MATURATION; CELL STRUCTURE; CLINICAL ARTICLE; FEMALE; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; B-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM NEOPLASMS; DNA, NEOPLASM; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GERMINAL CENTER; HUMANS; IMMUNOCOMPETENCE; IMMUNOENZYME TECHNIQUES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTEIN-TYROSINE-PHOSPHATASE; SHP1 PROTEIN TYROSINE PHOSPHATASE; SRC HOMOLOGY DOMAINS; TUMOR MARKERS, BIOLOGICAL;

EID: 4644239383     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2004.01677.x     Document Type: Article

References (24)

1. Kleihues P, Cavenee WK, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press, 2000; 198-203.
2. Chang C, Kampalath B, Schultz C et al. Expression of p53, c-Myc, or Bcl-6 suggests for a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals. Arch Pathol Lab Med 2003; 127: 208-12.
3. Nozaki M, Tada M, Mizugaki Y et al. Expression of oncogenic molecules in primary central nervous system lymphomas in immunocompetent patients. Acta Neuropathol 1998; 95: 505-10.
4. Sekita T, Tamaru J, Kaito K, Katayama T, Kobayashi M, Mikata A. Primary central nervous system lymphomas express Vh genes with intermediate to high somatic mutations. Leukemia Lymphoma 2001; 41: 377-58.
5. Larocca LM, Capello D, Rinelli A et al. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 1998; 92: 1011-19.
6. Thompsett AR, Ellison DW, Steveson FK, Zhu D. VH gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity. Blood 1999; 94: 1738-46.
7. Pani G, Kozlowski M, Cambier JC, Mills GB, Siminovitch KA. Identification for the tyrosine phosphatase PTPIC as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. J Exp Med 1995; 181: 2077-84.
8. Chen HE, Chang S, Trub T, Neel BG. Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 1996; 16: 3685-97.
9. Delibrias CC, Floettmann JE, Rowe M, Fearon DT. Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes. J Exp Med 1997; 186: 1575-83.
10. Kossev PM, Raghunath PN, Bagg A, Schuster S, Tomaszewski JE, Wasik MA. SHP-1 expression by malignant small B-cell lymphomas reflects the maturation stage of their normal B-cell counterparts. Am J Surg Pathol 2001; 25: 949-55.
11. Paessler M, Kossev P, Tsai D et al. Expression of SHP-1 phosphatase indicates post-germinal center cell derivation of B cell posttransplant lymphoproliferative disorders. Lab Invest 2002; 11: 1599-606.
12. Zhang Q, Raghunath PN, Vondereheid E, Odum N, Wasik MA. Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of SHP-1 promoter. Am J Pathol 2000; 157: 1137-46.
13. Oka T, Yoshino T, Hayashi K et al. Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/ leukemias. Am J Pathol 2001; 159: 1495-505.
14. Ma X-Z, Jin T, Sakac D et al. Abnormal splicing of SHP-1 protein tyrosine phosphatase in human T cells: implication for lymphomagenesis. Exp Hematol 2003; 31: 131-42.
15. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue. Lyon, IARC Press, 2001; 171-4.
16. Dogan A, Bagdi E, Munson P, Issacson PG. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol 2000; 24: 846-52.
17. Ree JH, Oshima K, Aozasa K et al. Detection of germinal center B-cell lymphoma in archival specimens: Critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsil. Hum Pathol 2003; 34: 610-15.
18. de Leval L, Braaten KM, Ancukiewicz M et al. Diffuse large B-cell lymphoma of bone. An analysis of differentiation-associated antigens with clinical correlation. Am J Surg Pathol 2003; 27: 1269-77.
19. Huebner-Chan D, Fernandes B, Yang G, Lim MS. An immunophenotypic and molecular study of primary large B cell lymphoma of bone. Mod Pathol 2001; 14: 1000-1007.
20. Kido S, Miyazaki K, Tokunaga O. The relationship between primary gastric B-cell lymphoma and immunoglobulin heavy chain (IgH) gene rearrangement - A histopathological study of primary gastric lymphomas. Pathol Res Prac 2003; 199: 647-58.
21. Boonstra R, Koning A, Mastik M, van den Berg A, Poppema S. Analysis of chromosomal copy number changes and oncoprotein expression in primary central nervous system lymphomas: frequent loss of chromosome arm 6q. Virchows Arch 2003; 443: 164-9.
22. Kepes JJ. Pitfalls and problems in the histopathologic evaluation of stereotactic needle biopsy specimens. Neurosurg Clin N Am 1994; 5: 19-33.
23. Taratuto AL, Sevlever G, Piccardo P. Clues and pitfalls in stereotactic biopsy of the central nervous system. Arch Pathol Lab Med 1991; 115: 596-602.
24. Derksen PW, Langerak AW, Kerkhof E et al. Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangement in B-cell neoplasia. Mod Pathol 1999; 12: 794-805.